Raquitismo hipofosfatêmico ligado ao X: estudo de caso familiar e perspectivas da reabilitação
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
X-Linked Hypophosphatemic Rickets (RHLX) is the most prevalent hereditary
rickets form with a dominant inheritance pattern, attributed to mutations in the
PHEX gene. These mutations lead to elevated levels of Fibroblast Growth
Factor-23 (FGF-23) and subsequent phosphate loss. RHLX affects about 1 in
20,000 people. This condition causes persistent hypophosphatemia due to
increased urinary phosphate excretion, resulting in skeletal deformities, short
stature, and various medical symptoms. The current study aimed to conduct a
genealogical analysis of a family with documented cases of RHLX and to
discuss the prospects for rehabilitation, especially physical therapy
interventions. Data collection involved interviews and clinical records, leading to
the construction of a pedigree illustrating family relationships and affected
individuals. Interviews with two family members yielded a five-generation
pedigree, revealing two affected individuals: a woman in generation IV and her
son (the proband) in generation V. The clinical report for the child, issued in
2023 by the medical team at Hospital Sarah Kubitschek in Belo Horizonte,
Minas Gerais, indicated progressive bowing of lower limbs, short stature, and
laboratory findings consistent with RHLX. Given that this condition follows an X-
linked dominant inheritance pattern, the pathogenic mutation in the PHEX gene
was transmitted from mother to proband, suggesting a 50% risk for affected
women to have affected offspring, regardless of sex. Recent international
guidelines recommend multidisciplinary follow-ups for these patients, where
physical therapy can play a crucial role in treatment and improve rehabilitation
quality of life. However, we noted the absence of specific therapeutic guidelines
and/or programs in Brazil and a lack of controlled, randomized clinical studies to
validate their efficacy.
Description
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

